Clinical Trial

The Effect of Nanofat Injection on Androgenetic Alopecia

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Androgenetic alopecia is a condition that bothers a lot of people. The disadvantage of the FDA approved topical minoxidil is that the patient needs to be compliant every day for extended periods of time. This is the main reason why this study is being conducted, to see if a single nanofat injection is superior to applying either topical Minoxidil or PRP
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-06.
Trial Details
NCT Number NCT07518342
Lead Sponsor Assiut University
Conditions Androgenetic Alopecia, Androgenetic Alopecia (AGA)
Enrollment 60 participants
Start Date 2026-04
Primary Completion 2028-06 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-13